ProShare Advisors’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $924K | Sell |
|
|||||
|
2025
Q1 | $799K | Sell |
|
|||||
|
2024
Q4 | $623K | Buy |
|
|||||
|
2024
Q3 | $485K | Buy |
|
|||||
|
2024
Q2 | $294K | Sell |
|
|||||
|
2024
Q1 | $379K | Buy |
|
|||||
|
2023
Q4 | $282K | Buy |
|
|||||
|
2023
Q3 | $521K | Buy |
|
|||||
|
2023
Q2 | $440K | Buy |
|
|||||
|
2023
Q1 | $281K | Sell |
|
|||||
|
2022
Q4 | $458K | Buy |
|
|||||
|
2022
Q3 | $213K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $223K | Sell |
|
|||||
|
2021
Q3 | $240K | Sell |
|
|||||
|
2021
Q2 | $321K | Buy |
|
|||||
|
2021
Q1 | $244K | Buy |
|
|||||
|
2020
Q4 | $216K | Buy |
|
|||||
|
2020
Q3 | $223K | Buy |
|